Haemolysis and acute kidney injury in paediatric ECMO [descriptive label — exact article title VERIFICATION REQUIRED]

Certainty
Moderate
Chapters

29, 55, 37

Clinical implication

Haemolysis identifies real organ-specific harm beyond the neurological signal, and the renal endpoint is the better-powered one. Supports treating sub-threshold haemolysis as a finding rather than noise.

Comparator

Children without elevated haemolysis markers

Design
Retrospective cohort
Identifier

Strong AE, Zee J, Fulchiero R, Kilbaugh TJ, Connelly J, Makeneni S, Campos D, Laskin BL, Denburg MR. Kidney360 2023;4(11):1536-1544. DOI 10.34067/KID.0000000000000253

Intervention

Elevated plasma free haemoglobin and elevated lactate dehydrogenase as time-varying exposures, with the pre-ECMO creatinine as baseline

Limitations

Retrospective; paediatric, so extrapolation to adults is indirect

Link
Main result

Free haemoglobin — described by the authors as the most specific of the haemolysis markers — carried an adjusted HR of 2.9 (1.4 to 5.6) for a composite of acute kidney injury or renal replacement therapy, rising to 6.6 (3.3 to 13.2) for stage 2 or worse injury. LDH gave 3.1 and 2.8 respectively.

Population

501 children on ECMO

Verified
Year
2023